MARKET

WVE

WVE

WAVE LIFE SCIENC
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.65
+0.09
+1.18%
Opening 11:54 01/27 EST
OPEN
7.45
PREV CLOSE
7.56
HIGH
7.73
LOW
7.35
VOLUME
159.76K
TURNOVER
--
52 WEEK HIGH
48.64
52 WEEK LOW
7.22
MARKET CAP
262.28M
P/E (TTM)
-1.4309
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of WVE and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

WVE News

  • New FDA documents shed light on agency's rejection of Sarepta drug
  • American City Business Journals.5d ago
  • Wave Life Sciences Enters Oversold Territory
  • Zacks.01/16 14:39
  • Wave Life Sciences Enters Oversold Territory
  • Zacks.01/14 14:55
  • The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate Merger
  • Benzinga.01/03 12:55

More

Industry

Biotechnology & Medical Research
-0.99%
Pharmaceuticals & Medical Research
-0.45%

Hot Stocks

Name
Price
%Change

About WVE

WAVE Life Sciences Ltd. is a genetic medicines company. The Company, through its synthetic chemistry drug development platform, designs, develops and commercializes a pipeline of nucleic acid therapeutic candidates for genetically defined diseases. The Company is engaged in developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. The nucleic acid therapeutics, which the Company is developing are stereopure. A stereopure oligonucleotide includes molecules with atoms arranged in three-dimensional orientations at each linkage. The Company has three programs in Huntington's disease (HD) and Duchenne Muscular Dystrophy (DMD), and three additional development candidates.
More

Webull offers Wave Life Sciences Ltd (WVE) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.